newsflashIntroducing: micro-Matrix,

the next generation in microbioreactors

The unique micro-Matrix offers total control over 24 independent bioreactors in a simple microtiter plate footprint.Each of the 24 bioreactors on a plate offer independent controls like its larger stirred-tank relatives:

• pH (measurement and two-sided control)
• temperature (measurement and two-sided control, including plate-wide gradients)• dissolved oxygen control (measurement and two-sided control)
• individual liquid additions (including feeding profiles)
• up to 4 separate gas additions (individually controlled)


 MMAtrix 02 View06





Grand opening of Applikon Biotechnology China factory in Guangzhou.

Wednesday March 19th the Chinese factory of Applikon Biotechnology in Guangzhou has officially been opened. The presence of Chinese and Dutch goverment officials, highlighted the importance of this new milestone in the rapid development of our company. The factory is already operational since the end of 2013 and has assembled over 50 bioreactor systems. This extra capacity is needed to be able to cope with the increasing demand for Applikon bioreactors in China, the USA and in the rest of the world.
The opening ceremony was combined with a seminar titled:Innovations in bioreactor technology". International speakers presented new developments in bioreactor technology and showed the results of scientific cooperations between Applikon Biotechnology and several Universities.






King Willem-Alexander has opened our new headquarters


Opening klein 

On Wednesday December 4th the new headquarters of Applikon Biotechnology in Delft, the Netherlands has been officially opened by His Majesty King Willem-Alexander of the Netherlands. The grand opening was attended by (inter)national customers, business relations,(inter)national officials, scientific relations and the entire team of the Applikon Biotechnology in the Netherlands.

The new production facility has been operational for several months and the official opening was to officially mark this further step in the development and growth of Applikon Biotechnology. Company owners Arthur Oudshoorn, Jaap Oostra and Erik Kakes, and their dedicated team are proud and happy with these new premises which house the state-of-the-art warehouse and production facilities, R&D laboratory space and offices for approximately 100 employees.

In this new facility, Applikon Biotechnology  is now able to provide a complete range of bioreactor systems ranging from micro liter research volumes up to 15.000 liter production systems for pharmaceutical and biotechnological applications. 



BioSenz Glucose Bio Analyzer


The Applikon BioSenz is a unique measuring device specifically developed for analysing glucose in bioreactors.

The heat-flux technology is a proprietary and patented technology for continuous measurement with high precision and repeatability. The technology that is used in intensive care units and other medical applications is brought to the biotech industry to finally allow accurate measurement of glucose in bioprocesses without interference from other medium compounds.


Applikon Biotechnology introduces smallest BioSep perfusion device

Schiedam, the Netherlands, April, 2013 – Applikon Biotechnology introduces the latest  and smallest family member of the BioSep accoustic perfusion system family; the 1 l/day BioSep. This mini BioSep is designed to work with small scale bioreactor systems and is the smallest perfusion device on the market.

<< Start < Prev 1 2 Next > End >>

Page 1 of 2
     Go to top   










© Copyright 2013 Applikon Biotechnology